RecruitingNCT04807712

Pediatric Pertussis in Ambulatory Settings

National Surveillance of Pediatric Pertussis in Ambulatory Settings


Sponsor

Association Clinique Thérapeutique Infantile du val de Marne

Enrollment

898 participants

Start Date

May 30, 2001

Study Type

OBSERVATIONAL

Conditions

Summary

Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).


Eligibility

Min Age: 1 DayMax Age: 18 Years

Inclusion Criteria1

  • All children under 18 years old with a pertussis diagnosis is suspected and a biological exam is requested

Exclusion Criteria2

  • children without symptoms with a household confirmed case
  • cases for which the pertussis diagnosis was not suspected by the pediatrician

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERnon interventional study

Locations(1)

ACTIV

Créteil, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04807712


Related Trials